Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity

Abstract Background Intratumoral heterogeneity emerges from accumulating genetic and epigenetic changes during tumorigenesis, which may contribute to therapeutic failure and drug resistance. However, the lack of a quick and convenient approach to determine the intratumoral epigenetic heterogeneity (...

Full description

Saved in:
Bibliographic Details
Main Authors: Binbin Liu, Yumo Xie, Yu Zhang, Guannan Tang, Jinxin Lin, Ze Yuan, Xiaoxia Liu, Xiaolin Wang, Meijin Huang, Yanxin Luo, Huichuan Yu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cell & Bioscience
Subjects:
Online Access:https://doi.org/10.1186/s13578-024-01337-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585360091119616
author Binbin Liu
Yumo Xie
Yu Zhang
Guannan Tang
Jinxin Lin
Ze Yuan
Xiaoxia Liu
Xiaolin Wang
Meijin Huang
Yanxin Luo
Huichuan Yu
author_facet Binbin Liu
Yumo Xie
Yu Zhang
Guannan Tang
Jinxin Lin
Ze Yuan
Xiaoxia Liu
Xiaolin Wang
Meijin Huang
Yanxin Luo
Huichuan Yu
author_sort Binbin Liu
collection DOAJ
description Abstract Background Intratumoral heterogeneity emerges from accumulating genetic and epigenetic changes during tumorigenesis, which may contribute to therapeutic failure and drug resistance. However, the lack of a quick and convenient approach to determine the intratumoral epigenetic heterogeneity (eITH) limit the application of eITH in clinical settings. Here, we aimed to develop a tool that can evaluate the eITH using the DNA methylation profiles from bulk tumors. Methods Genomic DNA of three laser micro-dissected tumor regions, including digestive tract surface, central bulk, and invasive front, was extracted from formalin-fixed paraffin-embedded sections of colorectal cancer patients. The genome-wide methylation profiles were generated with methylation array. The most variable methylated probes were selected to construct a DNA methylation-based heterogeneity (MeHEG) estimation tool that can deconvolve the proportion of each reference tumor region with the support vector machine model-based method. A PCR-based assay for quantitative analysis of DNA methylation (QASM) was developed to specifically determine the methylation status of each CpG in MeHEG assay at single-base resolution to realize fast evaluation of epigenetic heterogeneity. Results In the discovery set with 79 patients, the differentially methylated CpGs among the three tumor regions were found. The 7 most representative CpGs were identified and subsequently selected to develop the MeHEG algorithm. We validated its performance of deconvolution of tumor regions in an independent cohort. In addition, we showed the significant association of MeHEG-based epigenetic heterogeneity with the genomic heterogeneity in mutation and copy number variation in our in-house and TCGA cohorts. Besides, we found that the patients with higher MeHEG score had worse disease-free and overall survival outcomes. Finally, we found dynamic change of epigenetic heterogeneity based on MeHEG score in cancer cells under the treatment of therapeutic drugs. Conclusion By developing a 7-loci panel using a machine learning approach combined with the QASM assay for PCR-based application, we present a valuable method for evaluating intratumoral heterogeneity. The MeHEG algorithm offers novel insights into tumor heterogeneity from an epigenetic perspective, potentially enriching current knowledge of tumor complexity and providing a new tool for clinical and research applications in cancer biology.
format Article
id doaj-art-758f3523dda645f2bd2161882863187d
institution Kabale University
issn 2045-3701
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cell & Bioscience
spelling doaj-art-758f3523dda645f2bd2161882863187d2025-01-26T12:54:19ZengBMCCell & Bioscience2045-37012025-01-0115111610.1186/s13578-024-01337-ySpatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneityBinbin Liu0Yumo Xie1Yu Zhang2Guannan Tang3Jinxin Lin4Ze Yuan5Xiaoxia Liu6Xiaolin Wang7Meijin Huang8Yanxin Luo9Huichuan Yu10Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen UniversityDepartment of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen UniversityDepartment of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen UniversityDepartment of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen UniversityDepartment of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen UniversityAbstract Background Intratumoral heterogeneity emerges from accumulating genetic and epigenetic changes during tumorigenesis, which may contribute to therapeutic failure and drug resistance. However, the lack of a quick and convenient approach to determine the intratumoral epigenetic heterogeneity (eITH) limit the application of eITH in clinical settings. Here, we aimed to develop a tool that can evaluate the eITH using the DNA methylation profiles from bulk tumors. Methods Genomic DNA of three laser micro-dissected tumor regions, including digestive tract surface, central bulk, and invasive front, was extracted from formalin-fixed paraffin-embedded sections of colorectal cancer patients. The genome-wide methylation profiles were generated with methylation array. The most variable methylated probes were selected to construct a DNA methylation-based heterogeneity (MeHEG) estimation tool that can deconvolve the proportion of each reference tumor region with the support vector machine model-based method. A PCR-based assay for quantitative analysis of DNA methylation (QASM) was developed to specifically determine the methylation status of each CpG in MeHEG assay at single-base resolution to realize fast evaluation of epigenetic heterogeneity. Results In the discovery set with 79 patients, the differentially methylated CpGs among the three tumor regions were found. The 7 most representative CpGs were identified and subsequently selected to develop the MeHEG algorithm. We validated its performance of deconvolution of tumor regions in an independent cohort. In addition, we showed the significant association of MeHEG-based epigenetic heterogeneity with the genomic heterogeneity in mutation and copy number variation in our in-house and TCGA cohorts. Besides, we found that the patients with higher MeHEG score had worse disease-free and overall survival outcomes. Finally, we found dynamic change of epigenetic heterogeneity based on MeHEG score in cancer cells under the treatment of therapeutic drugs. Conclusion By developing a 7-loci panel using a machine learning approach combined with the QASM assay for PCR-based application, we present a valuable method for evaluating intratumoral heterogeneity. The MeHEG algorithm offers novel insights into tumor heterogeneity from an epigenetic perspective, potentially enriching current knowledge of tumor complexity and providing a new tool for clinical and research applications in cancer biology.https://doi.org/10.1186/s13578-024-01337-yDNA methylationIntratumor heterogeneityEpigeneticColorectal cancer
spellingShingle Binbin Liu
Yumo Xie
Yu Zhang
Guannan Tang
Jinxin Lin
Ze Yuan
Xiaoxia Liu
Xiaolin Wang
Meijin Huang
Yanxin Luo
Huichuan Yu
Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
Cell & Bioscience
DNA methylation
Intratumor heterogeneity
Epigenetic
Colorectal cancer
title Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
title_full Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
title_fullStr Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
title_full_unstemmed Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
title_short Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
title_sort spatial deconvolution from bulk dna methylation profiles determines intratumoral epigenetic heterogeneity
topic DNA methylation
Intratumor heterogeneity
Epigenetic
Colorectal cancer
url https://doi.org/10.1186/s13578-024-01337-y
work_keys_str_mv AT binbinliu spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT yumoxie spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT yuzhang spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT guannantang spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT jinxinlin spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT zeyuan spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT xiaoxialiu spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT xiaolinwang spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT meijinhuang spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT yanxinluo spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity
AT huichuanyu spatialdeconvolutionfrombulkdnamethylationprofilesdeterminesintratumoralepigeneticheterogeneity